Wisconsin Pharmacal Company: Mg217 Multi-symptom Treatment Cream & Skin Protectant (colloidal Oatmeal 2%)
Recall Summary Pharmacal is recalling one lot of MG217 Multi-Symptom Treatment Cream & Skin Protectant Eczema Cream (6oz tubes) because the product was found to contain Staphylococcus aureus bacteria. The recall affects products distributed nationwide and was issued in May 2026. The contaminated product could pose a health risk to consumers who use it.
- Recalling firm
- Wisconsin Pharmacal Company
- Product
- MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%), NET WT 6 oz (170 g), Manufactured by: Pharmacal 1 Pharmacal Way, P.O. Box 198, Jackson, WI 53037.
- Reason
- Microbial Contamination of Non-Sterile Products: confirmed presence of Staphylococcus Aureus.
- Classification
- Class I
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-04-24
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- USA Nationwide and Bahamas
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/c7aa43fd-6f15-469c-b674-a513726d40de